Ando N, Kato H, Igaki H et al (2011) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19(1):68–74. https://doi.org/10.1245/s10434-011-2049-9

Article  PubMed  Google Scholar 

Eyck BM, Lanschot JJB, Hulshof MCCM et al (2021) Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol 39(18):1995–2004. https://doi.org/10.1200/jco.20.03614

Article  CAS  PubMed  Google Scholar 

Yang H, Liu H, Chen Y et al (2021) Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma. JAMA Surg 156(8):721. https://doi.org/10.1001/jamasurg.2021.2373

Article  PubMed  PubMed Central  Google Scholar 

Yang H, Liu H, Chen Y et al (2018) Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol 36(27):2796–2803. https://doi.org/10.1200/jco.2018.79.1483

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hagen P, Hulshof MCCM, Lanschot JJB et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084. https://doi.org/10.1056/nejmoa1112088

Article  PubMed  Google Scholar 

Meredith KL, Weber JM, Turaga KK et al (2010) Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol 17(4):1159–1167. https://doi.org/10.1245/s10434-009-0862-1

Article  PubMed  Google Scholar 

Chevrollier GS, Giugliano DN, Palazzo F et al (2020) Patients with non-response to neoadjuvant chemoradiation for esophageal cancer have no survival advantage over patients undergoing primary esophagectomy. J Gastrointest Surg 24(2):288–298. https://doi.org/10.1007/s11605-019-04161-9

Article  PubMed  Google Scholar 

Al-Kaabi A, Post RS, Werf LR et al (2021) Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study. Acta Oncol 60(4):497–504. https://doi.org/10.1080/0284186x.2020.1870246

Article  CAS  PubMed  Google Scholar 

Abraham AG, Riauka T, Hudson M et al (2023) 18F-fluorodeoxyglucose positron emission tomography parameters can predict long-term outcome following trimodality treatment for oesophageal cancer. Clin Oncol 35(3):177–187. https://doi.org/10.1016/j.clon.2022.11.003

Article  CAS  Google Scholar 

Lee B, Lee CG (2022) Significance of mid-radiotherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography in esophageal cancer. Radiother Oncol 171:114–120. https://doi.org/10.1016/j.radonc.2022.04.009

Article  PubMed  Google Scholar 

Kim N, Cho H, Yun M, Park KR, Lee CG (2019) Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer. Radiat Oncol. https://doi.org/10.1186/s13014-019-1232-1

Article  PubMed  PubMed Central  Google Scholar 

Alfieri R, Pintacuda G, Cagol M et al (2014) Oesophageal cancer: assessment of tumour response to chemoradiotherapy with tridimensional CT. Radiol Med 120(5):430–439. https://doi.org/10.1007/s11547-014-0466-0

Article  PubMed  Google Scholar 

Liang S, Li C, Gao Z, Shang D, Yu J, Meng X (2021) The predictive value of tumor volume and its change on short-term outcome for esophageal squamous cell carcinoma treated with radiotherapy or chemoradiotherapy. Front Oncol 10:586145. https://doi.org/10.3389/fonc.2020.586145

Article  PubMed  PubMed Central  Google Scholar 

Wu Y, Tang S, Tan B et al (2021) Tumor stage-based gross tumor volume of resectable esophageal squamous cell carcinoma measured on CT: association with early recurrence after esophagectomy. Front Oncol. https://doi.org/10.3389/fonc.2021.753797

Article  PubMed  PubMed Central  Google Scholar 

Bremm J, Brunner S, Celik E et al (2024) Correlation of primary tumor volume and histopathologic response following neoadjuvant treatment of esophageal adenocarcinoma. Eur J Surg Oncol 50(4):108003. https://doi.org/10.1016/j.ejso.2024.108003

Article  PubMed  Google Scholar 

Guo H, Tang H-T, Hu W-L et al (2023) The application of radiomics in esophageal cancer: predicting the response after neoadjuvant therapy. Front Oncol. https://doi.org/10.3389/fonc.2023.1082960

Article  PubMed  PubMed Central  Google Scholar 

Fan L, Yang Z, Chang M, Chen Z, Wen Q (2024) CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients. J Transl Med. https://doi.org/10.1186/s12967-024-05392-4

Article  PubMed  PubMed Central  Google Scholar 

Hu Y, Xie C, Yang H et al (2021) Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma. Radiother Oncol 154:6–13. https://doi.org/10.1016/j.radonc.2020.09.014

Article  CAS  PubMed  Google Scholar 

Li Z, Wang F, Zhang H et al (2024) A radiomics strategy based on CT intra-tumoral and peritumoral regions for preoperative prediction of neoadjuvant chemoradiotherapy for esophageal cancer. Eur J Surg Oncol 50(4):108052. https://doi.org/10.1016/j.ejso.2024.108052

Article  PubMed  Google Scholar 

Hu Y, Xie C, Yang H et al (2020) Assessment of intratumoral and peritumoral computed tomography radiomics for predicting pathological complete response to neoadjuvant chemoradiation in patients with esophageal squamous cell carcinoma. JAMA Netw Open 3(9):e2015927. https://doi.org/10.1001/jamanetworkopen.2020.15927

Article  PubMed  PubMed Central  Google Scholar 

Becker K, Mueller JD, Schulmacher C et al (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98(7):1521–1530. https://doi.org/10.1002/cncr.11660

Article  PubMed  Google Scholar 

Huang R, Guo H, Chen J et al (2020) Intratreatment tumor volume change during definitive chemoradiotherapy is predictive for treatment outcome of patients with esophageal carcinoma. Manag Res 12:7331–7339. https://doi.org/10.2147/cmar.s246500

Article  Google Scholar 

Yang Z, He B, Zhuang X et al (2019) CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. J Radiat Res 60(4):538–545. https://doi.org/10.1093/jrr/rrz027

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beukinga RJ, Hulshoff JB, Dijk LV et al (2016) Predicting response to neoadjuvant chemoradiotherapy in esophageal cancer with textural features derived from pretreatment 18F-FDG PET/CT imaging. J Nucl Med 58(5):723–729. https://doi.org/10.2967/jnumed.116.180299

Article  CAS  PubMed  Google Scholar 

Beukinga RJ, Hulshoff JB, Mul VEM et al (2018) Prediction of response to neoadjuvant chemotherapy and radiation therapy with baseline and restaging 18F-FDG PET imaging biomarkers in patients with esophageal cancer. Radiology 287(3):983–992. https://doi.org/10.1148/radiol.2018172229

Article  PubMed  Google Scholar 

Rossum PSN, Fried DV, Zhang L et al (2016) The incremental value of subjective and quantitative assessment of 18F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer. J Nucl Med 57(5):691–700. https://doi.org/10.2967/jnumed.115.163766

Article  CAS  PubMed  Google Scholar 

Qu J, Zhang Y, Lu S et al (2022) Quantitative RECIST derived from multiparametric MRI in evaluating response of esophageal squamous cell carcinoma to neoadjuvant therapy. Eur Radiol 32(10):7295–7306. https://doi.org/10.1007/s00330-022-09111-9

Article  PubMed  Google Scholar 

Borggreve AS, Heethuis SE, Boekhoff MR et al (2019) Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer. Eur Radiol 30(4):1896–1907. https://doi.org/10.1007/s00330-019-06513-0

Article  PubMed  PubMed Central  Google Scholar 

Van Rossum PS, Van Lier AL, Van Vulpen M et al (2015) Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiother Oncol 115(2):163–170.